Insights on Options Market Activity for Soleno Therapeutics
Investors with significant capital have adopted a notably positive perspective on Soleno Therapeutics. As we examine the options trading pattern for Soleno Therapeutics (NASDAQ: SLNO), we've identified 10 distinct trades.
Analyzing each trade reveals that approximately 70% of these investments were initiated with optimistic expectations, while 30% were opened with a bearish outlook.
Out of the total trades observed, four involved puts, totaling around $265,110, while six consisted of calls, amounting to around $523,533.
Anticipated Price Targets Based on Investor Sentiment
From the trading activities noted, it seems that major investors are targeting a price range between $40.00 and $70.00 for Soleno Therapeutics over the past three months. This insight correlates with the trading behavior and expectations of key market players.
Understanding Volume and Open Interest Trends
Monitoring volume and open interest is essential in options trading. This information allows traders to gauge liquidity and understand the level of market interest in Soleno Therapeutics’ options for specific strike prices. In the previous 30 days, we have closely observed the fluctuations in both volume and open interest concerning calls and puts within the price range of $40.00 to $70.00.
Overview of Recent Options Activity
Recent trading data has drawn attention to several noteworthy activities. Here’s a glimpse into the significant trades and sentiments related to SOLN:
Options Activity Summary:
- Symbol: SLNO - CALL | Sentiment: BEARISH | Expiration: 01/17/25 | Price: $0.80 | Total Trade Price: $202.7K
- Symbol: SLNO - PUT | Sentiment: BULLISH | Expiration: 01/17/25 | Price: $0.30 | Total Trade Price: $133.4K
- Symbol: SLNO - CALL | Sentiment: BULLISH | Expiration: 12/20/24 | Price: $2.90 | Total Trade Price: $129.3K
- Symbol: SLNO - CALL | Sentiment: BEARISH | Expiration: 04/17/25 | Price: $5.20 | Total Trade Price: $95.2K
- Symbol: SLNO - PUT | Sentiment: BULLISH | Expiration: 01/17/25 | Price: $3.00 | Total Trade Price: $76.8K
Company Overview: Soleno Therapeutics
Soleno Therapeutics Inc focuses on advancing unique therapeutics aimed at treating rare diseases. One of its notable products is Diazoxide Choline Controlled-Release tablets, designed specifically for managing Prader-Willi Syndrome. These tablets utilize diazoxide choline as an active component, a notable compound in rare disease management.
Current Market Dynamics for Soleno Therapeutics
- Currently trading at a volume of 1,138,044, the stock price for SLNO has risen by 1.58%, with shares priced at $58.12.
- RSI metrics indicate that the stock may be nearing overbought conditions.
- The upcoming earnings announcement is anticipated in approximately 99 days.
Market Analyst Insights
Recent evaluations from two market analysts have yielded a consensus target price of $71.5 for Soleno Therapeutics. An analyst from Oppenheimer has maintained an Outperform rating, aligning with a target price of $73. Conversely, HC Wainwright & Co. has reduced their rating to Buy, adjusting the target to $70 amidst market observations.
Adapting to Market Sentiments and Trends
Engaging in options trading carries inherent risks but presents opportunities for significant rewards. Smart traders often manage these risks by continuing their education, fine-tuning trade strategies, leveraging various indicators, and maintaining an acute awareness of market conditions. Stay updated on the latest trades and insights into Soleno Therapeutics with reliable sources.
Frequently Asked Questions
What is the current trading volume of Soleno Therapeutics?
The current trading volume for Soleno Therapeutics is approximately 1,138,044 shares.
What is the target price set by analysts for SLNO?
Analysts have established a consensus target price of $71.5 for Soleno Therapeutics.
What are the recent sentiments in options trading for SLNO?
Recent options trading shows a bullish sentiment dominating, with 70% of trades being bullish.
What is Soleno Therapeutics known for?
Soleno Therapeutics is known for its focus on developing therapeutics for rare diseases, particularly its treatment for Prader-Willi Syndrome.
When is the next earnings release for Soleno Therapeutics?
The anticipated earnings release is expected in approximately 99 days.
